Cargando…

Cardiovascular status after Kawasaki disease in the UK

OBJECTIVE: Kawasaki disease (KD) is an acute vasculitis that causes coronary artery aneurysms (CAA) in young children. Previous studies have emphasised poor long-term outcomes for those with severe CAA. Little is known about the fate of those without CAA or patients with regressed CAA. We aimed to s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, V, Christov, G, Mukasa, T, Brogan, K S, Wade, A, Eleftheriou, D, Levin, M, Tulloh, RM, Almeida, B, Dillon, MJ, Marek, J, Klein, N, Brogan, PA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Coronary Artery Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621377/ https://www.ncbi.nlm.nih.gov/pubmed/26316045 http://dx.doi.org/10.1136/heartjnl-2015-307734

Ejemplares similares

Management of Kawasaki disease
por: Eleftheriou, D, et al.
Publicado: (2014)

Coronary artery stenosis risk and time course in Kawasaki disease patients: experience at a US tertiary pediatric centre
por: Patel, Alok Sunil, et al.
Publicado: (2015)

UK perspective on the changing landscape of non-invasive cardiac testing
por: Asher, Alex, et al.
Publicado: (2019)

Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK
por: Crowe, Francesca, et al.
Publicado: (2020)

Interaction between access choice and pharmacotherapy for coronary intervention: the results of a UK survey
por: Kinnaird, Tim D, et al.
Publicado: (2014)

Outcomes following PCI in CABG candidates during the COVID‐19 pandemic: The prospective multicentre UK‐ReVasc registry
por: Kite, Thomas A., et al.
Publicado: (2021)

Cost-effectiveness of cardiovascular imaging for stable coronary heart disease
por: Walker, Simon, et al.
Publicado: (2021)

Sleep apnoea and cardiovascular outcomes after coronary artery bypass grafting
por: Koo, Chieh Yang, et al.
Publicado: (2020)

Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease
por: Nissen, Steven E, et al.
Publicado: (2022)

Sex differences in mortality in stable patients undergoing vasodilator stress cardiovascular magnetic resonance
por: Miñana, Gema, et al.
Publicado: (2021)

Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
por: Ishak, Divan, et al.
Publicado: (2023)

Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Associations between cardiac troponin, mortality and subsequent use of cardiovascular services: differences in sex and ethnicity
por: Winchester, David E, et al.
Publicado: (2018)

Biological effect on drug distribution and vascular healing via paclitaxel‐coated balloon technology in drug eluting stent restenosis swine model
por: Li, Yan, et al.
Publicado: (2015)

Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

Influence of cardiovascular risk factors on infarct size and interaction with mechanical ischaemic postconditioning in ST-elevation myocardial infarction
por: Pichot, Sophie, et al.
Publicado: (2015)

Assessing the severity of cardiovascular disease in 213 088 patients with coronary heart disease: a retrospective cohort study
por: Zghebi, Salwa S, et al.
Publicado: (2021)

Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
por: Noman, Awsan, et al.
Publicado: (2016)

Risk prediction in stable cardiovascular disease using a high-sensitivity cardiac troponin T single biomarker strategy compared to the ESC-SCORE
por: Biener, Moritz, et al.
Publicado: (2018)

Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials
por: Bangalore, Sripal, et al.
Publicado: (2014)

Associations of health-related quality of life with major adverse cardiovascular and cerebrovascular events for individuals with ischaemic heart disease: systematic review, meta-analysis and evidence mapping
por: Soloveva, Anzhela, et al.
Publicado: (2023)

Contemporary percutaneous management of coronary calcification: current status and future directions
por: Hennessey, Breda, et al.
Publicado: (2023)

Association of protein-energy wasting and inflammation status with mortality after coronary revascularisation in patients on haemodialysis
por: Kumada, Yoshitaka, et al.
Publicado: (2020)

MicroRNA 8059 as a marker for the presence and extent of coronary artery calcification
por: Howlett, Philippa, et al.
Publicado: (2018)

Duration of dual antiplatelet therapy and stability of coronary heart disease: a 60 000-patient meta-analysis of randomised controlled trials
por: Bularga, Anda, et al.
Publicado: (2021)

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention
por: Krenn, Lisa, et al.
Publicado: (2014)

Differences in relative and absolute effectiveness of oral P2Y(12) inhibition in men and women: a meta-analysis and modelling study
por: Lee, Kuan Ken, et al.
Publicado: (2018)

Using electronic health records to predict costs and outcomes in stable coronary artery disease
por: Asaria, Miqdad, et al.
Publicado: (2016)

Clinical determinants of plasma cardiac biomarkers in patients with stable chest pain
por: Bing, Rong, et al.
Publicado: (2019)

Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy
por: Stewart, Ralph A H, et al.
Publicado: (2018)

Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome
por: Chapman, Andrew R, et al.
Publicado: (2019)

Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial
por: Williams, Michelle C, et al.
Publicado: (2017)

Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial
por: Adamson, Philip D, et al.
Publicado: (2018)

Implementation of an early rule-out pathway for myocardial infarction using a high-sensitivity cardiac troponin T assay
por: Sandeman, Dennis, et al.
Publicado: (2021)

Effects of Oral Testosterone Treatment on Myocardial Perfusion and Vascular Function in Men With Low Plasma Testosterone and Coronary Heart Disease
por: Webb, Carolyn M., et al.
Publicado: (2008)

Treatment of Heart Failure With Normal Ejection Fraction
por: Hamdani, Nazha, et al.
Publicado: (2010)

Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project
por: Quinn, Tom, et al.
Publicado: (2014)

The Manchester Acute Coronary Syndromes (MACS) decision rule for suspected cardiac chest pain: derivation and external validation
por: Body, Richard, et al.
Publicado: (2014)

A prospective, observational, multicentre study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI (STEPP—AMI)
por: Victor, Suma M, et al.
Publicado: (2014)

The diagnostic and prognostic value of coronary CT angiography in asymptomatic high-risk patients: a cohort study
por: Plank, Fabian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g7onho4l2clefoiplv2g04hhos